Viewing Study NCT06122961


Ignite Creation Date: 2025-12-24 @ 12:36 PM
Ignite Modification Date: 2025-12-28 @ 12:11 AM
Study NCT ID: NCT06122961
Status: COMPLETED
Last Update Posted: 2025-05-09
First Post: 2023-11-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)
Sponsor: Novo Nordisk A/S
Organization:

Study Overview

Official Title: Prevalence of Systemic Inflammation in Patients With Atherosclerotic Cardiovascular Disease and Heart Failure
Status: COMPLETED
Status Verified Date: 2025-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: POSEIDON
Brief Summary: This study will collect medical and background information from participants with diseases that affect the heart and blood vessels (cardiovascular disease). Participants will continue their normal care and will not get any treatment other than those the study doctor has prescribed.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
U1111-1286-3420 OTHER World Health Organization (WHO) View